Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BB Biotech AG BBAGF

Full chart Compare
Set alert

Price alert · BBAGF

All alert types
76.06 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

33.65 Day range 33.65
33.65 52-week range 76.06
YTD
-0.00%
1 year
-0.00%

Financial health

Altman Z-Score

66.47 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 2
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 4
  • P/B 3

Valuation

P/E 5.7×
FY 2016: -3.7×FY 2017: 5.4×FY 2018: -7.3×FY 2019: 5.4×FY 2020: 5.4×FY 2021: -9.5×FY 2022: -10.8×FY 2023: -17.0×FY 2024: 50.0×FY 2025: 5.7×
FY 2016 5y median -9.5× FY 2025
P/S 5.6×
FY 2016: -3.7×FY 2017: 5.4×FY 2018: -7.4×FY 2019: 5.4×FY 2020: 5.3×FY 2021: -9.7×FY 2022: -11.1×FY 2023: -18.1×FY 2024: 33.9×FY 2025: 5.6×
FY 2016 5y median -9.7× FY 2025
P/B 1.2×
FY 2016: 1.0×FY 2017: 1.1×FY 2018: 1.2×FY 2019: 1.1×FY 2020: 1.0×FY 2021: 1.2×FY 2022: 1.4×FY 2023: 1.5×FY 2024: 1.7×FY 2025: 1.2×
FY 2016 5y median 1.4× FY 2025
P/FCF 10.7×
FY 2016: 25.7×FY 2017: 14.2×FY 2018: 31.8×FY 2019: 17.1×FY 2020: 14.2×FY 2021: -40.5×FY 2022: 16.7×FY 2023: 16.1×FY 2024: 12.4×FY 2025: 10.7×
FY 2016 5y median 12.4× FY 2025
EV/EBITDA 5.5×
FY 2016: -3.9×FY 2017: 5.6×FY 2018: -8.4×FY 2019: 5.6×FY 2020: 5.5×FY 2021: -10.4×FY 2022: -12.0×FY 2023: -19.0×FY 2024: 48.6×FY 2025: 5.5×
FY 2016 5y median -10.4× FY 2025
EV/Sales 5.5×
FY 2016: -4.0×FY 2017: 5.5×FY 2018: -7.7×FY 2019: 5.5×FY 2020: 5.4×FY 2021: -10.6×FY 2022: -12.1×FY 2023: -19.7×FY 2024: 35.0×FY 2025: 5.5×
FY 2016 5y median -10.6× FY 2025
FCF Yield 9.4%
FY 2016: 3.9%FY 2017: 7.0%FY 2018: 3.1%FY 2019: 5.9%FY 2020: 7.0%FY 2021: -2.5%FY 2022: 6.0%FY 2023: 6.2%FY 2024: 8.0%FY 2025: 9.4%
FY 2016 5y median 6.2% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.2%FY 2022: 100.5%FY 2023: 103.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.2% FY 2025
Operating Margin 98.5%
FY 2016: 3.5%FY 2017: 99.2%FY 2018: 7.8%FY 2019: 98.9%FY 2020: 100.1%FY 2021: 13.3%FY 2022: 11.1%FY 2023: 106.6%FY 2024: 75.6%FY 2025: 98.5%
FY 2016 5y median 75.6% FY 2025
Net Margin 98.5%
FY 2016: 100.7%FY 2017: 99.2%FY 2018: 101.2%FY 2019: 98.9%FY 2020: 98.8%FY 2021: 102.4%FY 2022: 102.4%FY 2023: 106.6%FY 2024: 68.0%FY 2025: 98.5%
FY 2016 5y median 102.4% FY 2025
ROE 20.8%
FY 2016: -26.7%FY 2017: 19.4%FY 2018: -16.3%FY 2019: 20.0%FY 2020: 17.8%FY 2021: -12.3%FY 2022: -13.3%FY 2023: -8.9%FY 2024: 3.3%FY 2025: 20.8%
FY 2016 5y median -8.9% FY 2025
ROIC 20.8%
FY 2016: -0.9%FY 2017: 18.9%FY 2018: -1.2%FY 2019: 19.1%FY 2020: 18.0%FY 2021: -1.6%FY 2022: -1.4%FY 2023: -8.9%FY 2024: 3.5%FY 2025: 20.8%
FY 2016 5y median -1.4% FY 2025
ROA 20.8%
FY 2016: -24.9%FY 2017: 18.9%FY 2018: -15.3%FY 2019: 19.1%FY 2020: 17.4%FY 2021: -11.1%FY 2022: -11.7%FY 2023: -7.8%FY 2024: 3.2%FY 2025: 20.8%
FY 2016 5y median -7.8% FY 2025

Growth (YoY)

Revenue 425.9%
FY 2016: -220.8%FY 2017: 187.0%FY 2018: -167.2%FY 2019: 247.1%FY 2020: 2.0%FY 2021: -156.5%FY 2022: 11.6%FY 2023: 44.6%FY 2024: 157.6%FY 2025: 425.9%
FY 2016 FY 2025
Operating Income 585.1%
FY 2016: -104.3%FY 2017: 2554.0%FY 2018: -105.3%FY 2019: 1963.2%FY 2020: 3.3%FY 2021: -107.5%FY 2022: 26.6%FY 2023: -434.8%FY 2024: 140.9%FY 2025: 585.1%
FY 2016 FY 2025
EPS (diluted) 665.2%
FY 2016: -224.2%FY 2017: 185.6%FY 2018: -168.5%FY 2019: 243.7%FY 2020: 2.0%FY 2021: -158.6%FY 2022: 11.1%FY 2023: 42.0%FY 2024: 136.6%FY 2025: 665.2%
FY 2016 FY 2025
Free Cash Flow 1.5%
FY 2016: 119.5%FY 2017: 128.3%FY 2018: -59.1%FY 2019: 99.5%FY 2020: 22.1%FY 2021: -136.1%FY 2022: 343.8%FY 2023: -5.6%FY 2024: 39.5%FY 2025: 1.5%
FY 2016 FY 2025

Financial Health

Current Ratio 22.1×
FY 2016: 7.1×FY 2017: 3.1×FY 2018: 6.9×FY 2019: 8.7×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 8.4×FY 2024: 0.0×FY 2025: 22.1×
FY 2016 5y median 0.0× FY 2025
Quick Ratio 22.1×
FY 2016: 7.1×FY 2017: 3.1×FY 2018: 6.9×FY 2019: 8.7×FY 2020: 52.5×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 8.4×FY 2024: 0.0×FY 2025: 22.1×
FY 2016 5y median 0.0× FY 2025
Debt / Equity 0.0×
FY 2016: 0.1×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.2×
FY 2016: -0.2×FY 2017: 0.1×FY 2018: -0.4×FY 2019: 0.2×FY 2020: 0.1×FY 2021: -0.9×FY 2022: -1.0×FY 2023: -1.5×FY 2024: 1.5×FY 2025: -0.2×
FY 2016 5y median -0.9× FY 2025
Interest Coverage 10513×
FY 2016: -25.8×FY 2017: 1269×FY 2018: -33.5×FY 2019: 545×FY 2020: 793×FY 2021: -53.3×FY 2022: -22.4×FY 2023: -35.6×FY 2024: 17.0×FY 2025: 10513×
FY 2016 5y median -22.4× FY 2025

Dividends

Dividend Yield 3.0%
FY 2016: 5.4%FY 2017: 4.1%FY 2018: 5.3%FY 2019: 4.6%FY 2020: 5.0%FY 2021: 5.2%FY 2022: 5.5%FY 2023: 4.5%FY 2024: 2.9%FY 2025: 3.0%
FY 2016 5y median 4.5% FY 2025
Payout Ratio 17.0%
FY 2016: -20.0%FY 2017: 22.1%FY 2018: -38.8%FY 2019: 24.9%FY 2020: 27.3%FY 2021: -49.3%FY 2022: -59.3%FY 2023: -75.7%FY 2024: 144.5%FY 2025: 17.0%
FY 2016 5y median -49.3% FY 2025

Annual · latest fiscal year ends 2025-12-31